Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1989 Jan;52(1):18-22.
doi: 10.1136/jnnp.52.1.18.

A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis

Affiliations
Clinical Trial

A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis

D Bates et al. J Neurol Neurosurg Psychiatry. 1989 Jan.

Abstract

A trial of n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis has been conducted over a 5 year period. Ambulant patients (312) with acute remitting disease were randomly allocated to treatment or placebo. Both groups were given dietary advice to increase the intake of n-6 polyunsaturated fatty acids and the treatment group in addition received capsules containing n-3 polyunsaturated fatty acids. Analysis of clinical outcome at the end of 2 years of treatment was made in terms of the duration, frequency and severity of relapses and the number of patients who had improved or remained unchanged. The results showed no significant difference at the usual 95% confidence limits but there was a trend in favour of the group treated with n-3 polyunsaturated fatty acids in all parameters examined.

PubMed Disclaimer

References

    1. Biochimie. 1974;56(4):623-4 - PubMed
    1. Acta Neurol Scand. 1983 Mar;67(3):151-63 - PubMed
    1. Lancet. 1956 Apr 7;270(6919):381-3 - PubMed
    1. Br Med J. 1978 Nov 18;2(6149):1390-1 - PubMed
    1. Acta Neurol Scand. 1973;49(3):345-54 - PubMed

Publication types